Lmr Partners LLP Novo Nordisk A S Call Options Transaction History

Lmr Partners LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 07, 2024	BUY	$119.07 - $145.42 $6.95 Million - $8.49 Million	58,400 Added 25.67%	285,900 $34 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $809,886 - $969,606	6,600 Added 2.99%	227,500 $32.5 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $21 Million - $27.9 Million	205,300 Added 1316.03%	220,900 $28.4 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $16.1 Million - $19.3 Million	-183,400 Reduced 92.16%	15,600 $1.61 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $10.6 Million - $23.2 Million	116,200 Added 140.34%	199,000 $18.1 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $12.9 Million - $14.3 Million	82,800 New	82,800 $13.4 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.